Impact Factor
4.16
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.03
2,706 total citations
h5-index
62
h5 depth signal
Cited share
84.5%
473 of 560
Total citations
2,706
Citation footprint
Metric signal
4.66
External metric anchor
Self-citation
3.8%
104 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,498
China
774
United Kingdom
287
Italy
249
Germany
219
Citing Fields of Research
Neurosciences
2,058
Neurodegenerative Disorders
731
Substance Abuse
624
Cellular Membrane Transporters & Receptors
513
Anesthetic & Pain Medicine
498
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
15,020
Articles tracked across the journal lifetime
Indexed publication set
560
473 cited publications
Last 12 months
372
31.0 publications/month
Open access share
39.2%
146 OA publications in the last year
Leading citing country
United States
1,498 citing publications
Leading citing field
Neurosciences
2,058 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v9n1,Jan. 1970-
v9n1,Jan. 1970-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurosciences
Neurodegenerative Disorders
Anesthetic & Pain Medicine
Substance Abuse
Cellular Membrane Transporters & Receptors
Broad Categories
Neurology
Pharmacology
Neurosciences
Substance Abuse
Neurodegenerative Disorders
Anesthetic & Pain Medicine
Cellular Membrane Transporters & Receptors
MeSH Descriptors
Autonomic Agents
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1016/j.neuropharm.2026.111231
Open DOI
Subanesthetic ketamine modulates region-specific neural and endocrine responses to acute stress in rats
03
DOI 10.1016/j.neuropharm.2026.111230
Open DOI
Therapeutic potential and toxicological trade-offs of nanoparticle-enhanced valproic acid in glioblastoma: Behavioral and oxidative insights
04
DOI 10.1016/j.neuropharm.2026.111226
Open DOI
zDHHC11 is a common palmitoyltransferase regulating microglia-mediated neuroinflammation across neurodegenerative diseases
05
DOI 10.1016/j.neuropharm.2026.111232
Open DOI
Cholinergic-Dependent Metaplasticity in the Amygdala–Insula Pathway During Incubation of Cocaine Craving
06
DOI 10.1016/j.neuropharm.2026.111224
Open DOI
N-acetylcysteine decreases toluene conditioned place preference and modulates corticostriatal activity in adolescent rats
07
DOI 10.1016/j.neuropharm.2026.111228
Open DOI
Gallic acid attenuates PTSD-like behavioral and hippocampal neuroplasticity deficits induced by single prolonged stress in male rats
08
09
DOI 10.1016/j.neuropharm.2026.111223
Open DOI
Thyrotropin-releasing hormone increases dorsal premammillary nucleus neuron activity and darting behavior
10
DOI 10.1016/j.neuropharm.2026.111225
Open DOI
Psychoneuroimmunology of glioblastoma: How emotional states shape tumor biology
Bibliographical & Catalog Notes
Also available online.
Continues the International journal of neuropharmacology.
Vol. 28, no. 9 (1989)19920909 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper